Published in Drug Week, November 23rd, 2001
"Treatment of latent Mycobacterium tuberculosis infection with isoniazid can cause hepatotoxicity, but the risk of isoniazid-associated hepatotoxicity among persons coinfected with hepatitis C virus (HCV) is unknown," according to Pankaj Sadaphal and colleagues at Johns Hopkins University in Baltimore, the Baltimore City Health Department, the New York Academy of Medicine's Center for Urban Epidemiologic Studies, and Virco Laboratories in Mechelen, Belgium.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.